
<table style="text-align:center"><caption><strong>EU Market Authorization Counts for Orphan Drugs with Over 1 Market Authorization</strong></caption>
<tr><td colspan="2" style="border-bottom: 1px solid black"></td></tr><tr><td>Generic Name</td><td>Market Authorizations</td></tr>
<tr><td colspan="2" style="border-bottom: 1px solid black"></td></tr><tr><td>glivec</td><td>6</td></tr>
<tr><td>nexavar</td><td>3</td></tr>
<tr><td>revlimid</td><td>3</td></tr>
<tr><td>carbaglu</td><td>2</td></tr>
<tr><td>soliris</td><td>2</td></tr>
<tr><td>torisel</td><td>2</td></tr>
<tr><td>tracleer</td><td>2</td></tr>
<tr><td>yondelis</td><td>2</td></tr>
<tr><td>zavesca</td><td>2</td></tr>
<tr><td colspan="2" style="border-bottom: 1px solid black"></td></tr></table>
